Skip to main content
Journal of Cell Communication and Signaling logoLink to Journal of Cell Communication and Signaling
. 2014 Mar 7;8(2):113–124. doi: 10.1007/s12079-014-0230-1

The integrin needle in the stromal haystack: emerging role in corneal physiology and pathology

Sunil K Parapuram 1,2,, William Hodge 1
PMCID: PMC4063993  PMID: 24604397

Abstract

Several studies have established the role of activated corneal keratocytes in the fibrosis of the cornea. However, the role of keratocytes in maintaining the structural integrity of a normal cornea is less appreciated. We focus on the probable functions of integrins in the eye and of the importance of integrin-mediated keratocyte interactions with stromal matrix in the maintenance of corneal integrity. We point out that further understanding of how keratocytes interact with their matrix could establish a novel direction in preventing corneal pathology including loss of structural integrity as in keratoconus or as in fibrosis of the corneal stroma.

Keywords: Cornea, Keratocytes, Corneal stroma, Extracellular matrix, Integrins, Keratoconus


The simple cellular organization of the cornea is belied by its fascinating specialization for transparency. The cornea has three main tissue layers, the outer epithelium, the stroma in the middle and the inner endothelial layer. The stromal connective tissue, the layer mainly responsible for the corneal configuration, constituting nearly 80 % of the thickness of the cornea, is extremely resilient, capable of resisting intraocular pressure and protecting the posterior structures of the eye. The stromal tissue consists of lamellae of orthogonally arranged collagen fibrils surrounded by proteoglycans; in between the lamellae of collagen are found the keratocytes. The near-orderly arrangement of collagen lamellae, the narrow diameter of the collagen fibrils, regular interfibrillar space, associated proteoglycans and the expression of crystalline proteins in the keratocytes (Birk 2001; Kao and Liu 2002; Jester et al. 2007; Hassell and Birk 2010) are some of the main factors responsible for corneal transparency. Consequently, the factors affecting corneal transparency such as fibrotic changes due to disease or injury are problems primarily associated with the stroma. Thus it is important to achieve further understanding of the mechanisms by which the stroma acquires and maintains its structural integrity and its transparency.

Loss of corneal transparency is the second leading cause of blindness affecting the general population worldwide (Whitcher et al. 2001). The lack of orderly arrangement of the newly deposited stromal extracellular matrix (ECM) after a penetrating wound of the cornea (McCally et al. 2007) or after inflammatory corneal diseases (herpes simplex virus, infectious ulcers, rosacea) is an impediment to the transmission of light through the cornea. Occurrence of edema in the stroma as in Fuchs’ dystrophy or after surgical intervention is also known to hinder the transmission of light (Portellinha et al. 2001; Meek et al. 2003; Elhalis et al. 2010). The integrity of the stroma is important for many other clinically important topics as well; shape disorders of the cornea such as keratoconus, keratoglobus, pellucid marginal degeneration (Krachmer et al. 1984) often need surgical intervention, while correction of shape disorders of the cornea such as astigmatism is achieved by the multi-billion dollar spectacle and contact lens industry. The equally beneficial refractive surgery industry uses excimer laser to reshape the curvature of the stroma to achieve vision without glasses (McDonnell 1999).

Although several studies have expanded our understanding of the importance of structural components by which cornea remains transparent, very few investigations explore the role of keratocyte cells in a normal corneal stroma; they are generally considered quiescent having left the cell cycle (Francesconi et al. 2000; Jester et al. 2007). This is unexpected, considering that the keratocytes are the cells mainly responsible for the production of stromal extracellular matrix (ECM) (Cintron et al. 1983; Haustein 1983) and probably are mainly responsible for the unique arrangement and assembly of the matrix. A theme of importance that has not seen the limelight, mostly due to absence of in vivo studies, is the role of mechanical communication of keratocytes with their extracellular environment in maintaining corneal structural integrity. Cell-ECM interaction is critical for communicating the state of the mechanical environment to the cell as well as in mediating cellular response to a variety of stimuli (Pedersen and Swartz 2005). We discuss the role of keratocyte-integrins and ECM components in the maintenance of the stromal structure in a normal cornea and the restoration of stromal integrity after corneal disease or injury.

Constituents of corneal stromal ECM

Collagen is the primary constituent of the stromal matrix and include collagen types I, V, VI, VIII, XII, XIII and XIV (Quantock and Young 2008). The major collagen of the stroma is collagen type I and it forms heterotypic fibrils with collagen type V (Birk et al. 1988). Some collagens are detected in the stroma only during certain phases of corneal development and include type XIV collagen (may have a role in stromal fibrillogenesis (Young et al. 2002)), type XV collagen (may influence corneal avascularity (Saika et al. 2004)) and type XXIV collagen (may regulate type I collagen fibrillogenesis (Koch et al. 2003)).

In Mov13 mutant mouse, which does not synthesize collagen I, there was normal cellular organization during corneal morphogenesis, but the stroma lacked orthogonal organization of collagen lamellae and had markedly less collagen; also collagen fibrils present were of smaller fibril diameter than in normal cornea (Bard and Kratochwil 1987). Patients with Ehlers-Danlos syndrome due to COL5A1 haploinsufficiency or exon-skipping mutation in COL5A2 had thinner corneas. Collagen V regulates collagen fibril assembly and Col5a1-haploinsufficient mouse had opacity of cornea, thinner stroma, disorganized lamellae and fewer collagen fibrils with larger diameters (Segev et al. 2006; Sun et al. 2011). Lack of collagen type VIII leads to dysgenesis of the anterior segment in mice with protrusion of anterior chamber and thin corneal stroma (Hopfer et al. 2005). Further, there is increased expression of type XIII collagen in the myofibroblasts of stromal scar tissue in keratoconus corneas, indicating a role in wound healing (Maatta et al. 2006) (Table 1).

Table 1.

Established functions of extracellular matrix components of the corneal stroma

Gene disruption / knockout / mutation Corneal / stromal phenotype / disease References
Collagen, type I, alpha 1 Less collagen, lack of orthogonal organization, smaller fibril diameter (Bard and Kratochwil 1987)
Collagen, type V, alpha 1 / 2 Opacity of cornea, thinner stroma, disorganized lamellae, fewer collagen fibrils, larger fibril diameter; Ehlers-Danlos syndrome (Segev et al. 2006; Sun et al. 2011)
Collagen, type VIII, alpha 1 and alpha 2 Dysgenesis of the anterior segment: keratoglobus-like protrusion, thin corneal stroma, thin Descemet’s membrane, reduced number of endothelial cells; Fuch’s endothelial dystrophy and posterior polymorphous corneal dystrophy (Biswas et al. 2001; Hopfer et al. 2005)
Lumican / fibromodulin / PRELP / opticin High myopia (Wang et al. 2006; Majava et al. 2007)
Lumican Corneal opacity, larger collagen fibril diameter, disorganized collagen arrangement (Chakravarti et al. 1998)
Keratocan Thinner stroma, larger collagen fibril diameter, less organized fibrils; cornea plana (Pellegata et al. 2000; Liu et al. 2003)
N-acetylglucosamine-6-O-sulfotransferase Thinner stroma, decreased interfibrillar spacing, disorganized collagen arrangement; macular corneal dystrophy (Midura et al. 1990; Hayashida et al. 2006)
Decorin Mild changes in collagen ultrastructure; congenital stromal dystrophy (Bredrup et al. 2005; Zhang et al. 2009)
Biglycan Mild changes in collagen ultrastructure (Zhang et al. 2009)
Decorin and biglycan Severe disruption of collagen fibril structure and organization (Zhang et al. 2009)
Mimecan No significant abnormalities (Beecher et al. 2005)
Thrombospondin-1 Chronic edema and persistent opacity following penetrating corneal injury (Blanco-Mezquita et al. 2013)
Osteopontin Upon corneal injury: delayed wound healing, fewer myofibroblasts, reduced expression of TGF-β (Miyazaki et al. 2008)
Hevin Upon corneal injury: excessive apoptosis, aberrant wound healing, early corneal haze, severe chronic inflammation, stromal fibrosis (Chaurasia et al. 2013)
Tenascin-C Upon corneal injury: delayed stromal wound healing, impaired keratocyte migration, fewer myofibroblasts, less invasion of macrophages, reduced expression of TGF-β (Matsuda et al. 1999; Sumioka et al. 2013)

Proteoglycans are found associated with collagen fibrils in the corneal stroma; they have a core protein with one or more glycosaminoglycan (GAG) side chains covalently attached. Corneal proteoglycans mainly belong to the small leucine-rich type proteoglycan (SLRP) gene family and include decorin, biglycan, lumican, keratocan, mimecan and fibromodulin. Decorin and biglycan have chondroitin / dermatan sulfate GAG chain attached to their core protein; while lumican, keratocan, mimecan and fibromodulin have keratan sulfate GAG chains. Decorin and keratocan are present in relatively high levels throughout the stroma in mature corneas (Chakravarti et al. 2006; Zhang et al. 2009). In contrast, post-natal keratocytes had low-immunoreactivity for mimecan (Chakravarti et al. 2006). Fibromodulin has been found in the mouse central cornea at post-natal day (P) 14 but becomes restricted to the limbus by P30 (Chen et al. 2010). Similarly, biglycan was expressed highly during corneal development but gradually decreased to low levels in mature cornea (Zhang et al. 2009) and lumican becomes restricted to posterior stroma in adult cornea (Chakravarti et al. 2006). These SLRPs have similar or homologous core protein and along with their GAG chains are also similar in size and thus considered to have a role in maintaining the regular distance between collagen fibrils in the corneal stroma (Hassell and Birk 2010). They are also involved in collagen fibril growth, fibril organization and ECM assembly (Chen et al. 2010; Chen and Birk 2013). SLRPs also regulate cell-matrix-interactions: for example, lumican modulated cell migration by binding to integrins (Lee et al. 2009; Zeltz et al. 2010); while decorin inhibited cell adhesion to fibronectin and thrombospondin (Winnemoller et al. 1991; Merle et al. 1997). Further, SLRPs have important role in modulation of inflammation (Moreth et al. 2012), and can regulate corneal wound healing (Mohan et al. 2011).

Loss of function mutations in genes encoding SLRPs lumican, fibromodulin, PRELP and opticin are associated with high myopia (Wang et al. 2006; Majava et al. 2007). Mice with null mutation in lumican develop corneal opacity with disorganized and abnormally thick collagen fibrils (Chakravarti et al. 1998); however, keratocan-deficient mice had normal corneal transparency despite thinner stroma, larger stromal fibril diameter and less organized collagen fibrils (Liu et al. 2003). People with mutations in the gene encoding keratocan suffer from cornea plana (Pellegata et al. 2000). Mutations in the gene that encodes a sulfotransferase that is vital for sulfation of keratan sulfate chains cause macular corneal dystrophy (Midura et al. 1990; Hayashida et al. 2006). Mutations in the decorin gene have been identified as the cause of corneal opacity as in congenital stromal dystrophy (Bredrup et al. 2005). Deficiency of either decorin or biglycan in mice caused only mild changes in stromal collagen ultrastructure; however deletion of both caused severe disruption of collagen fibril structure and organization (Zhang et al. 2009). Mimecan-deficient mice did not show significant abnormalities in corneal stromal architecture, indicating a lesser role for this proteoglycan (Beecher et al. 2005) (Table 1).

Matricellular proteins are non-structural ECM proteins that regulate cell function by interacting with and modulating the actions of cell-surface receptors, growth factors, cytokines, proteases, and matrix proteins (Bornstein and Sage 2002). Role of matricellular proteins such as hevin, connective tissue growth factor (CTGF / CCN2) and thrombospondin are less defined in a normal corneal stroma. However, matricellular proteins have an important role in wound healing (Kyriakides and Bornstein 2003) and their involvement in the corneal wound healing (Table 1) is discussed later in this review.

Identification of biological roles of various integrins

Cells interact with their extracellular matrix (ECM) mainly through integrin receptors. Integrins are glycoprotein heterodimers made of noncovalently associated α and β chains. The vertebrate family of integrins has 18 α subunits and 8 β subunits allowing 24 different heterodimers to exist, and are classified further into subgroups based either on their subunit composition or ligand-binding properties. They recognize and bind to aspartic acid or glutamic acid-based sequence motifs in various ligands, including collagen, fibronectin, laminin and growth factors (Hynes 2002; Barczyk et al. 2010). Mg2+, Ca2+ and Mn2+ cations are also known to have a crucial role in binding of integrins to their ligands (Arnaout et al. 2002; Campbell and Humphries 2011).

Though integrins have been identified to have a role in several diseases such as cancer, infection, thrombosis and autoimmune disorders, identifying a specific integrin involved or assigning a precise role has been difficult because of the multifactorial nature of most diseases and due to the multiple integrins present on the cells and their redundant binding properties (Cox et al. 2010). However, whole-body deletion of individual integrin subunits is allowing the identification of unique function of each integrin subunit (Hynes 2002; Chen and Sheppard 2007; Takada et al. 2007); such deletions though are usually lethal and involve studying of embryonic or neonatal mice. Among the breakthroughs, for example, is the recognition of the critical role of the β1 integrin subunit in gastrulation; whole-body deletion of β1 integrin resulted in lethality shortly after embryo implantation (Fassler and Meyer 1995; Stephens et al. 1995). Whole-body deletion of the α5 integrin caused embryonic lethality around day 10–11 due to abnormality in the development of the posterior trunk with reduced mesoderm and defects in formation of the neural tube and vasculature (Yang et al. 1993). On the other hand, mice harboring a whole-body deletion of the β2 integrin were viable but developed chronic dermatitis and defective T cell function with impaired leukocyte adhesion, neutrophil migration, leukocytosis and spontaneous infections (Scharffetter-Kochanek et al. 1998). So far, each of the 24 known integrin subunits have been inactivated resulting in various defects ranging from impaired bone healing, epidermal detachment, inflammation in skin and lungs, cerebral hemorrhage, kidney defect, heart defect and muscular dystrophy. In addition, the post-natal functions of individual integrins are also being deduced from a growing number of conditional cell-type-specific knockout animals that are becoming available, (see reviews (Hynes 2002; Chen and Sheppard 2007; Takada et al. 2007)). Though gene deletions allow us to understand the overall role of integrin subunits, the signaling mechanisms by which integrins regulate the function of various tissues have yet to make significant progress.

Established functions of integrins in the eye and their association to eye diseases

Though integrins are important for normal development and tissue homeostasis, their role in pathology / wound healing, largely perhaps, drives the interest in understanding their functions in the eye. This is because, unlike many other tissues, even minor disorganization of tissues of eye due to a pathology or injury can drastically affect normal vision. Modulating the activity of integrins could serve as valuable therapeutic targets (Kapp et al. 2013). Several studies have revealed the expression pattern of integrins in the tissues of the eye during development and in pathology (see reviews, (Stepp 2006; Vigneault et al. 2007; Carter 2009)), however, very few studies reveal their actual function in the eye.

In the eye, conditional deletion of integrin β1 in the lens causes microphthalmia due to apoptosis of the lens epithelium and disintegration of the lens fibers (Simirskii et al. 2007). In a similar study, there was disrupted lens fiber morphology that suggested a role for integrin β1 in linking lens fibers to the surrounding ECM (Samuelsson et al. 2007). Also, deactivation of both α3 and α6 results in dysmorphogenesis of the developing lens (De Arcangelis et al. 1999). αvβ5 is the only integrin present at the retinal pigment epithelium-photoreceptor interface and its absence resulted in reduced retinal adhesion and age-related blindness as αvβ5 integrin in the retinal pigment epithelium is essential for phagocytic uptake of shed photoreceptor disks (Nandrot et al. 2004). On the other hand, polarized integrin localization is required for normal morphogenesis of vertebrate retinal pigment epithelium (Bogdanovic et al. 2012). α4β1 was found to be required for survival of developing retinal neurons (Leu et al. 2004). Blocking of β1 integrins significantly inhibited retinal ganglion cells migration from ventricular zone to the vitreal border in developing chick retina (Cann et al. 1996).

Alterations in integrin expression have alluded to their importance and role in vascular changes associated with diabetic retinopathy (Robbins et al. 1994; Ljubimov et al. 1998), in corneal disorders such as bullous keratopathy (Spirin et al. 1999; Ljubimov et al. 2001), in recurrent epithelial erosions (Pal-Ghosh et al. 2004), and in keratoconus (Bystrom et al. 2009). Integrins are also among various factors that cause retinal detachment in proliferative diabetic retinopathy and proliferative vitreoretinopathy (Kupper and Ferguson 1993; Guidry et al. 2003). In rats, blockade of α4 integrin diminished diabetes-induced increase in NF-kappaB activation, VEGF and TNF-alpha levels and significantly reduced leukocyte adhesion and vascular leakage (Iliaki et al. 2009). Synthetic peptide antagonists of integrin αvβ3 inhibited retinal neovascularization in a murine model when administered as intraperitonal or periocular injections (Luna et al. 1996), inhibition of αv integrins prevented basic fibroblast growth factor-induced neovascularization of cornea (Klotz et al. 2000), and inhibition of α5β1 inhibited and regressed corneal neovascularization after alkali-burns (Muether et al. 2007). Blockade of α4β1 decreased dry eye symptoms and inflammation significantly (Ecoiffier et al. 2008). Furthermore, integrin signaling and integrin-linked kinase activity could affect the organization and contractility of actin cytoskeleton in trabecular meshwork cells (Faralli et al. 2011), a factor known to modulate aqueous humor outflow.

Role of integrins in the cornea

Corneal epithelium is known to express β1, β4, β5, α2,α3, α4, α5, α6 and αv (Lauweryns et al. 1991; Stepp et al. 1993), with α5, α6, and β4 localizing specifically to the basal membrane of the basal cells (Stepp et al. 1993) while keratocytes are known to express α2β1, α3β1, α4β1, α6β1 and αvβ3 (Stepp 2006). Several studies have reported alterations in the distribution and expression of integrins during corneal wound healing (Grushkin-Lerner and Trinkaus-Randall 1991; Murakami et al. 1992; Stepp et al. 1993, 1996; Latvala et al. 1996; Hutcheon et al. 2005; Carter 2009) indicating an important role for integrins in corneal homeostasis. For example, elevated MMP9 activity correlated with cleavage of integrin β4 and recurrent corneal erosions (Pal-Ghosh et al. 2011). cDNA microarray studies indicated that pathogenesis of granular corneal dystrophy II may be due to alterations in transforming growth factor-β receptor- and integrin-mediated signaling pathways (Choi et al. 2010). In wound healing after corneal epithelial abrasion, integrin α6 was detected in migrating epithelial cells (Latvala et al. 1996); and in final stages of wound healing repression of α6 integrin is thought to contribute to the reduced proliferation and attachment of epithelium to the basal membrane (Gaudreault et al. 2007). In an indirect inference, mice lacking heparan sulfate proteoglycan, syndecan-1, showed slow cell migration and reduced expression of α9 integrin during corneal epithelial wound closure (Stepp et al. 2002). In an in vitro study with implications for continuation of normal corneal health, αvβ6 was shown to have a role in the maintenance of corneal epithelial barrier (Guo et al. 2013). However, interpretation of the precise function of integrins in normal or wound healing cornea remains problematic as there is dearth of reports using integrin gene-knockout models. Thus, in a solitary study, mice lacking integrin β6 revealed that αvβ6 (which is upregulated in the corneal epithelium during wound healing (Hutcheon et al. 2005)) was essential for basement membrane zone regeneration during healing of keratectomy wounds (Blanco-Mezquita et al. 2011).

Integrin β1 and corneal structural integrity

It is in this scenario that keratocyte-integrin β1 (Itgb1) was found to have an important role in the maintenance of structural integrity of the normal adult cornea (Parapuram et al. 2011), with implications on corneal wound healing without scarring. Postnatal (at 23 to 26 days) deletion of Itgb1 (Itgb1−/−) in keratocytes caused considerable thinning of mice corneal stroma accompanied by loss of epithelial layers and other associated pathological changes similar to the pathology seen in the corneas of patients with keratoconus (Efron and Hollingsworth 2008). However, when Itgb1 was deleted in keratocytes at postnatal day 40 the mouse cornea remained normal, unlike the corneas that developed keratoconus-like phenotype when Itgb1 was deleted at postnatal days 23–26 (Parapuram et al. 2011). This implied that the deletion of Itgb1 at days 23–26 after birth somehow affected the process of postnatal stromal maturation. It is known that corneal structural organization continues to mature after birth in cats, dogs and humans (Ehlers et al. 1976; Moodie et al. 2001; Montiani-Ferreira et al. 2003). In humans, adult corneal thickness is reached at about 3 years of age (Ehlers et al. 1976). In the mouse, even though the keratocyte cell division plateaus about postnatal day 21, the stroma continues to mature, to reach adult thickness only by postnatal day 30 (Song et al. 2003; Chakravarti et al. 2006; Jester et al. 2007). However, the specific molecular events that allow maturation of the stroma remain unknown.

Stromal ECM maturation

Several factors could influence the formation of the stromal matrix and its maturation. Thus, even though collagen I can self-assemble to form fibrils in vitro, several other molecules, including other collagens, fibronectin and integrins regulate collagen fibril formation in vivo (Kadler et al. 2008). Collagen type V is involved in initiating fibril assembly (Wenstrup et al. 2004, 2006). Antibody against α2β1 integrin inhibited collagen fibril assembly by vascular smooth muscle cells, while promoting the high-affinity binding state of α2β1 integrin enhanced the fibril assembly (Li et al. 2003). Collagen fibril diameter, on the other hand, is known to be determined by the core proteins of lumican and decorin (Rada et al. 1993), proteoglycans present in the corneal stroma, as well as by type V collagen (Birk et al. 1990).

The thinning of Itgb1−/−corneas was not accompanied by any change in stromal collagen fibril diameter or gross proteoglycan deposition (Parapuram et al. 2011). However, instances of reduction in space between collagen fibrils in the Itgb1−/−corneas (Parapuram et al. 2011), indicate the inability of the matrix to resist strain; repulsive charges of proteoglycans, for example, are known to resist compression (Buschmann and Grodzinsky 1995). These observations in the Itgb1−/−corneas support the prevalent hypothesis that thinning of keratoconus cornea is attributable to increased sliding of the collagen and not due to loss of tissue (Polack 1976; Edmund 1988). Consistent with this viewpoint is the recent report of decreased expression of lysyl oxidase (LOX), the enzyme that is involved in the cross-linking collagen molecules as well as elastin, in keratoconus corneas (Dudakova et al. 2012). Reducing the formation of cross-links in collagen by inhibiting LOX is known to reduce the mechanical stability of matrix and decreased adhesion signaling (Bruel et al. 1998; Levental et al. 2009). Conversely, LOX-induced collagen cross-linking and tissue stiffening promoted integrin clustering and increased adhesion signaling (Levental et al. 2009). Few studies have indicated that the interlamellar and probably intralamellar slippage in keratoconus stroma is due to loss of cohesion between collagen fibrils and non-collagenous matrix (proteoglycans) (Fullwood et al. 1992; Daxer and Fratzl 1997; Meek et al. 2005). It is possible that tractional forces generated by keratocytes (Petroll et al. 2003) through integrins could provide appropriate spatial conditions for cross-linking by LOX or for proteoglycan-collagen interaction, thus facilitating proper maturation of matrix. In this context, it has to be noted that decreased expression of integrins has been reported in keratoconus corneas (Vorkauf et al. 1995; Tuori et al. 1997). Deficiency of magnesium, which is required for activation of integrins, has also been reported in patients with keratoconus (Thalasselis et al. 1988). Thus, it is highly likely that the etiology of keratoconus could be multifactorial but converge on a common mechanism that prevents matrix maturation during corneal development resulting in gradual development of the disease. Similarly, in a healing cornea conditions for proper maturation of newly laid matrix may be deficient and is perhaps the reason for its disorganized deposition. Consequently, keratocyte-matrix interactions and integrin signaling during the entire course of corneal development and in wound healing warrants further study.

Furthermore, maturation of the stromal matrix is perhaps vital for its role as a load-bearing structure. Diseases such as keratoconus paradoxically allow appreciation of the mechanical role of matrix in a normal cornea. The stromal matrix can shield the keratocytes from stress; for any external stress applied (such as the intraocular pressure) the matrix typically bears most of the stress, resulting in almost no load on the cells (Pedersen and Swartz 2005). It is possible that in keratoconus as well as in the Itgb1−/−corneas there is increased stress on the keratocytes due to loss of integrity of the matrix, affecting the normal physiology of keratocytes. We can only speculate presently that such stress could disrupt the growth factor-mediated communications between the keratocyte and corneal epithelium (Wilson et al. 1999; Imanishi et al. 2000) and is a cause for the reduced cell division of basal epithelia in the Itgb1−/− corneas (Parapuram et al. 2011). The necessity of a mature matrix is again evident as the swelling pressure caused by hydrophilic glycosaminoglycans is counteracted by the lamellar tension and the cohesive forces between lamellae (Klyce et al. 1971; Smolek and McCarey 1990; Dupps and Wilson 2006). Disruption of the lamellar tension and the cohesive forces between lamellae is considered a cause of edema (Dupps and Wilson 2006) and could be one explanation for the occurrence of edema in Itgb1−/− corneas. In fact, activation of integrin β1 signaling is known to reduce edema in other systems (Rodt et al. 1994) and this may also have relevance in treating corneal edema. Also, cross-linking of collagen to strengthen the stroma, a therapeutic strategy for management of keratoconus (Wollensak et al. 2003), is thus a logical substitute for the role of integrins in the development of stromal matrix into a resilient load-bearing structure.

Integrin-mediated events that modulate stromal wound healing

The wound healing events are complex and often occur simultaneously and are influenced by several factors (Netto et al. 2005). In cutaneous wound healing, integrins are implicated in all phases of wound repair, including migration of various types of cells, matrix remodeling and in wound contraction (Larsen et al. 2006; Li et al. 2007). Deletion of integrin β1 in fibroblasts delayed cutaneous wound closure, less granulation tissue formation, reduced deposition of ECM and α-smooth muscle actin expression (Liu et al. 2010). Proteoglycans, such as lumican can promote skin wound healing by enhancing α2β1 integrin-mediated fibroblast contractility (Liu et al. 2013). Also, integrins are now considered to regulate the availability of active transforming growth factor-β (TGF-β), the most potent stimulator of fibrosis, at the site of injury by protease-dependent and protease-independent mechanisms (Margadant and Sonnenberg 2010). The protease-independent TGF-β activation occurs through integrin-mediated cell traction forces (Annes et al. 2004; Fontana et al. 2005; Wipff et al. 2007; Wipff and Hinz 2008) and is likely to influence the outcome of corneal wound healing, especially being a structure that experiences tension. Isoforms TGF-β2 and -β3 have been localized in the matrix of normal stroma, while isoforms TGF-β1, −β2 and -β3 were expressed in the stromal cells during wound healing (Saika et al. 2008). Such activation of TGF-β by αvβ3, αvβ5, αvβ6 and αvβ8, as well as by β1-integrin with a yet unidentified α-subunit, has been demonstrated in vitro (Wipff and Hinz 2008); αvβ3, as noted earlier, is expressed by keratocytes.

In corneal wound healing, stromal keratocytes are activated by factors released by the injured corneal epithelium, by the neutrophils and lymphocytes that reach the site of injury and from the tear film (Klenkler and Sheardown 2004). The migration of neutrophil in injured mouse cornea is integrin-dependent and these neutrophils interact with keratocytes and prefer to migrate along the keratocyte network (Petrescu et al. 2007; Hanlon et al. 2014). These activated keratocytes proliferate to repopulate the region of stromal injury in which keratocytes have disappeared due to apoptosis (Helena et al. 1998; Wilson 2002). At 1–2 weeks after injury myofibroblasts, mostly differentiating from bone marrow-derived cells (Barbosa et al. 2010; Wilson 2012), and less transparent than keratocytes (Jester et al. 1999; Piatigorsky 2000) can be detected (Jester et al. 1995). Myofibroblasts deposit large amounts of ECM (Klingberg et al. 2013) that contributes to stromal opacity (Wilson 2012) and their contraction is associated with wound closure, compaction of matrix (Tomasek et al. 2002; Gabbiani 2003) and activation of latent TGF-β (Wipff et al. 2007). Myofibroblast apoptosis (Wilson and Chaurasia 2007) results in their disappearance slowly over weeks following restoration of corneal epithelial basement membrane after injury (Stramer et al. 2003; Dupps and Wilson 2006); conversely, corneal haze due to fibrosis is associated with persistent presence of myofibroblasts (Netto et al. 2005). Stromal scar tissue had markedly decreased levels of lumican (Sundarraj et al. 1998) and this may be related to TGF-β-induced keratocyte-myofibroblast transition that is known to decrease the expression of normal stromal proteoglycans lumican, keratocan, mimecan and decorin, but also increase the expression of biglycan, a proteoglycan present in fibrotic tissue (Funderburgh et al. 2001). Stromal scar tissue may take several years to resolve and may involve remodeling of disorganized stromal collagen (Netto et al. 2005) by keratocytes that repopulate the stroma after the disappearance of myofibroblasts (Wilson 2012).

Fibrosis is associated with increased integrin-mediated adhesion signaling in the myofibroblasts (Hinz et al. 2007; Wong et al. 2011). Relatedly, conduciveness for growth of a particular type of cell can be determined by the stiffness of the matrix (Georges et al. 2006; Carracedo et al. 2010) and may explain the persistent presence of highly adhesive and contractile myofibroblasts until remodeling of matrix occurs. In fibroblasts, blocking adhesion signaling through integrin β1 prevented an increase in alpha-smooth muscle actin positive stress fibers even in the presence TGF-β (Arora et al. 1999). Integrins, such as α11β1, α5β1, are known to regulate keratocyte to myofibroblast differentiation (Jester et al. 1994; Carracedo et al. 2010). Conversely, other studies have indicated that myofibroblastic differentiation required TGF-β and PDGF as well as synergistic signaling with integrins (Jester et al. 2002; Singh et al. 2011). Equally, autocrine TGF-β signaling is known to regulate conversion of keratocytes to myofibroblasts (Masur et al. 1996). On the other hand, overexpression of decorin in the keratocytes blocked TGF-β-mediated myofibroblast transformation of keratocytes (Mohan et al. 2010), while decorin gene therapy inhibited corneal scarring (Mohan et al. 2011). Also, decorin interacted with α2β1 in endothelial cells and modulated the collagen I binding activity of the integrin (Fiedler et al. 2008). Since α2β1 is also expressed in keratocytes, it should be interesting to know whether such integrin-decorin interaction has a part in stromal wound healing.

Non-structural matricellular proteins present in the ECM are known to influence corneal stromal wound healing. Secreted protein that is acidic and rich in cysteine (SPARC) is expressed by activated keratocytes adjacent to stromal wound and induced contraction of matrix by keratocytes (Mishima et al. 1998). Connective tissue growth factor (CTGF / CCN2) is also expressed by keratocytes and has a major role downstream of TGF-β in inducing fibrosis (Folger et al. 2001; Leask 2008). CTGF mediates its activity primarily through interaction with cell adhesion receptors, including integrins (e.g. α6β1, αvβ3) and heparan sulfate proteoglycans (Chen and Lau 2009) and also binds to mannose 6-phosphate / insulin-like growth factor 2 receptor on keratocytes (Blalock et al. 2012); IGF-2 has a major role in the development of fibrosis (Grotendorst et al. 2004). CCN3 (Nov) induced neovascularization when implanted in rat cornea and is a ligand of integrins αvβ3 and αvβ1 (Lin et al. 2003). Thrombospondins, usually produced by platelets during wound repair, are also produced in avascular cornea by keratocytes in a wound-repair phenotype (Hiscott et al. 1996; Armstrong et al. 2002). Thrombospondin-1 is implicated in the transformation of keratocytes into myofibroblasts via TGF-β (Matsuba et al. 2011) and is known to interact with different integrins to modulate inflammatory response, and cell migration (Li et al. 2002; Short et al. 2005; John et al. 2010). Thrombospondin-1 deficient mice have chronic edema and persistent opacity after penetrating corneal wounding (Blanco-Mezquita et al. 2013). Osteopontin (OPN) was also found to have a role in wound healing; wound healing was delayed and there were fewer myofibroblasts and TGF-β expression in the stromal wound of OPN knockout mice (Miyazaki et al. 2008). OPN is known to promote integrin activation in gastric cancer cells (Lee et al. 2007) and is upregulated along with αvβ3 during glial scar formation after focal stroke (Ellison et al. 1998). Hevin, though not expressed in normal cornea, is transiently expressed in early stages of stromal wound healing and excimer laser-induced irregular phototherapeutic keratectomy in hevin-null mice induced excessive apoptosis and aberrant wound healing, including early corneal haze, severe chronic inflammation and stromal fibrosis (Chaurasia et al. 2013). Tenascin was upregulated in the corneal stroma upon incision injury; delayed stromal wound healing was seen in tenascin C knockout mouse due to impaired keratocyte migration, myofibroblast differentiation and invasion of macrophages, along with reduced expression of TGF-β1 (Matsuda et al. 1999; Sumioka et al. 2013).

Hitherto, the importance of ECM components in maintaining the structural integrity of the cornea has been established unambiguously. In parallel, the current evidence also point to a fundamental role of keratocyte / integrin interactions with structural and non-structural matrix components in the development of normal corneal stroma and in regaining the integrity of the stroma after being affected by disease or injury. Keratocyte / myofibroblast and their integrins have a role in both normal wound healing as well as fibrosis, indicating that a delicate balance in their activity is required for normal healing to occur. Manipulations of integrin activity in keratocytes could be beneficial for regaining stromal integrity after being affected by disease or injury; the drug alpha-trinositol reduced edema due to acute inflammation after injury to skin by increasing integrin activity (Lund and Reed 1994; Rodt et al. 1994). Would enhancing integrin activity at crucial stages of corneal development increase the chance for normal maturation of matrix and prevent the development of keratoconus? A similar strategy may be employed for ordered matrix deposition during stromal wound healing; the exact role of integrins in normal stromal maturation will perhaps also reveal the elements required for transparency of newly deposited matrix. Further defining the events associated with integrin / keratocyte-mediated matrix maturation in the developing cornea as well as during wound healing thus remains a relevant strategy.

References

  1. Annes JP, Chen Y, Munger JS, Rifkin DB. Integrin alphaVbeta6-mediated activation of latent TGF-beta requires the latent TGF-beta binding protein-1. J Cell Biol. 2004;165(5):723–734. doi: 10.1083/jcb.200312172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Armstrong DJ, Hiscott P, Batterbury M, Kaye S. Corneal stromal cells (keratocytes) express thrombospondins 2 and 3 in wound repair phenotype. Int J Biochem Cell Biol. 2002;34(6):588–593. doi: 10.1016/s1357-2725(01)00157-1. [DOI] [PubMed] [Google Scholar]
  3. Arnaout MA, Goodman SL, Xiong JP. Coming to grips with integrin binding to ligands. Curr Opin Cell Biol. 2002;14(5):641–651. doi: 10.1016/s0955-0674(02)00371-x. [DOI] [PubMed] [Google Scholar]
  4. Arora PD, Narani N, McCulloch CA. The compliance of collagen gels regulates transforming growth factor-beta induction of alpha-smooth muscle actin in fibroblasts. Am J Pathol. 1999;154(3):871–882. doi: 10.1016/s0002-9440(10)65334-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Barbosa FL, Chaurasia SS, Cutler A, Asosingh K, Kaur H, et al. Corneal myofibroblast generation from bone marrow-derived cells. Exp Eye Res. 2010;91(1):92–96. doi: 10.1016/j.exer.2010.04.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Barczyk M, Carracedo S, Gullberg D. Integrins. Cell Tissue Res. 2010;339(1):269–280. doi: 10.1007/s00441-009-0834-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bard JB, Kratochwil K. Corneal morphogenesis in the Mov13 mutant mouse is characterized by normal cellular organization but disordered and thin collagen. Development. 1987;101(3):547–555. doi: 10.1242/dev.101.3.547. [DOI] [PubMed] [Google Scholar]
  8. Beecher N, Carlson C, Allen BR, Kipchumba R, Conrad GW, et al. An x-ray diffraction study of corneal structure in mimecan-deficient mice. Invest Ophthalmol Vis Sci. 2005;46(11):4046–4049. doi: 10.1167/iovs.05-0325. [DOI] [PubMed] [Google Scholar]
  9. Birk DE. Type V collagen: heterotypic type I/V collagen interactions in the regulation of fibril assembly. Micron. 2001;32(3):223–237. doi: 10.1016/s0968-4328(00)00043-3. [DOI] [PubMed] [Google Scholar]
  10. Birk DE, Fitch JM, Babiarz JP, Linsenmayer TF. Collagen type I and type V are present in the same fibril in the avian corneal stroma. J Cell Biol. 1988;106(3):999–1008. doi: 10.1083/jcb.106.3.999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Birk DE, Fitch JM, Babiarz JP, Doane KJ, Linsenmayer TF. Collagen fibrillogenesis in vitro: interaction of types I and V collagen regulates fibril diameter. J Cell Sci. 1990;95(Pt 4):649–657. doi: 10.1242/jcs.95.4.649. [DOI] [PubMed] [Google Scholar]
  12. Biswas S, Munier FL, Yardley J, Hart-Holden N, Perveen R, et al. Missense mutations in COL8A2, the gene encoding the alpha2 chain of type VIII collagen, cause two forms of corneal endothelial dystrophy. Hum Mol Genet. 2001;10(21):2415–2423. doi: 10.1093/hmg/10.21.2415. [DOI] [PubMed] [Google Scholar]
  13. Blalock TD, Gibson DJ, Duncan MR, Tuli SS, Grotendorst GR, et al. A connective tissue growth factor signaling receptor in corneal fibroblasts. Invest Ophthalmol Vis Sci. 2012;53(7):3387–3394. doi: 10.1167/iovs.12-9425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Blanco-Mezquita JT, Hutcheon AE, Stepp MA, Zieske JD. alphaVbeta6 integrin promotes corneal wound healing. Invest Ophthalmol Vis Sci. 2011;52(11):8505–8513. doi: 10.1167/iovs.11-8194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Blanco-Mezquita JT, Hutcheon AE, Zieske JD. Role of thrombospondin-1 in repair of penetrating corneal wounds. Invest Ophthalmol Vis Sci. 2013;54(9):6262–6268. doi: 10.1167/iovs.13-11710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Bogdanovic O, Delfino-Machin M, Nicolas-Perez M, Gavilan MP, Gago-Rodrigues I, et al. Numb/Numbl-Opo antagonism controls retinal epithelium morphogenesis by regulating integrin endocytosis. Dev Cell. 2012;23(4):782–795. doi: 10.1016/j.devcel.2012.09.004. [DOI] [PubMed] [Google Scholar]
  17. Bornstein P, Sage EH. Matricellular proteins: extracellular modulators of cell function. Curr Opin Cell Biol. 2002;14(5):608–616. doi: 10.1016/s0955-0674(02)00361-7. [DOI] [PubMed] [Google Scholar]
  18. Bredrup C, Knappskog PM, Majewski J, Rodahl E, Boman H. Congenital stromal dystrophy of the cornea caused by a mutation in the decorin gene. Invest Ophthalmol Vis Sci. 2005;46(2):420–426. doi: 10.1167/iovs.04-0804. [DOI] [PubMed] [Google Scholar]
  19. Bruel A, Ortoft G, Oxlund H. Inhibition of cross-links in collagen is associated with reduced stiffness of the aorta in young rats. Atherosclerosis. 1998;140(1):135–145. doi: 10.1016/s0021-9150(98)00130-0. [DOI] [PubMed] [Google Scholar]
  20. Buschmann MD, Grodzinsky AJ. A molecular model of proteoglycan-associated electrostatic forces in cartilage mechanics. J Biomech Eng. 1995;117(2):179–192. doi: 10.1115/1.2796000. [DOI] [PubMed] [Google Scholar]
  21. Bystrom B, Carracedo S, Behndig A, Gullberg D, Pedrosa-Domellof F. Alpha11 integrin in the human cornea: importance in development and disease. Invest Ophthalmol Vis Sci. 2009;50(11):5044–5053. doi: 10.1167/iovs.08-3261. [DOI] [PubMed] [Google Scholar]
  22. Campbell ID, Humphries MJ (2011) Integrin structure, activation, and interactions. Cold Spring Harb Perspect Biol 3(3) [DOI] [PMC free article] [PubMed]
  23. Cann GM, Bradshaw AD, Gervin DB, Hunter AW, Clegg DO. Widespread expression of beta1 integrins in the developing chick retina: evidence for a role in migration of retinal ganglion cells. Dev Biol. 1996;180(1):82–96. doi: 10.1006/dbio.1996.0286. [DOI] [PubMed] [Google Scholar]
  24. Carracedo S, Lu N, Popova SN, Jonsson R, Eckes B, et al. The fibroblast integrin alpha11beta1 is induced in a mechanosensitive manner involving activin A and regulates myofibroblast differentiation. J Biol Chem. 2010;285(14):10434–10445. doi: 10.1074/jbc.M109.078766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Carter RT. The role of integrins in corneal wound healing. Vet Ophthalmol. 2009;12(Suppl 1):2–9. doi: 10.1111/j.1463-5224.2009.00726.x. [DOI] [PubMed] [Google Scholar]
  26. Chakravarti S, Magnuson T, Lass JH, Jepsen KJ, LaMantia C, et al. Lumican regulates collagen fibril assembly: skin fragility and corneal opacity in the absence of lumican. J Cell Biol. 1998;141(5):1277–1286. doi: 10.1083/jcb.141.5.1277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Chakravarti S, Zhang G, Chervoneva I, Roberts L, Birk DE. Collagen fibril assembly during postnatal development and dysfunctional regulation in the lumican-deficient murine cornea. Dev Dyn. 2006;235(9):2493–2506. doi: 10.1002/dvdy.20868. [DOI] [PubMed] [Google Scholar]
  28. Chaurasia SS, Perera PR, Poh R, Lim RR, Wong TT, et al. Hevin plays a pivotal role in corneal wound healing. PLoS One. 2013;8(11):e81544. doi: 10.1371/journal.pone.0081544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Chen S, Birk DE. The regulatory roles of small leucine-rich proteoglycans in extracellular matrix assembly. FEBS J. 2013;280(10):2120–2137. doi: 10.1111/febs.12136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Chen CC, Lau LF. Functions and mechanisms of action of CCN matricellular proteins. Int J Biochem Cell Biol. 2009;41(4):771–783. doi: 10.1016/j.biocel.2008.07.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Chen C, Sheppard D. Identification and molecular characterization of multiple phenotypes in integrin knockout mice. Methods Enzymol. 2007;426:291–305. doi: 10.1016/S0076-6879(07)26013-6. [DOI] [PubMed] [Google Scholar]
  32. Chen S, Oldberg A, Chakravarti S, Birk DE. Fibromodulin regulates collagen fibrillogenesis during peripheral corneal development. Dev Dyn. 2010;239(3):844–854. doi: 10.1002/dvdy.22216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Choi SI, Yoo YM, Kim BY, Kim TI, Cho HJ, et al. Involvement of TGF-{beta} receptor- and integrin-mediated signaling pathways in the pathogenesis of granular corneal dystrophy II. Invest Ophthalmol Vis Sci. 2010;51(4):1832–1847. doi: 10.1167/iovs.09-4149. [DOI] [PubMed] [Google Scholar]
  34. Cintron C, Covington H, Kublin CL. Morphogenesis of rabbit corneal stroma. Invest Ophthalmol Vis Sci. 1983;24(5):543–556. [PubMed] [Google Scholar]
  35. Cox D, Brennan M, Moran N. Integrins as therapeutic targets: lessons and opportunities. Nat Rev Drug Discov. 2010;9(10):804–820. doi: 10.1038/nrd3266. [DOI] [PubMed] [Google Scholar]
  36. Daxer A, Fratzl P. Collagen fibril orientation in the human corneal stroma and its implication in keratoconus. Invest Ophthalmol Vis Sci. 1997;38(1):121–129. [PubMed] [Google Scholar]
  37. De Arcangelis A, Mark M, Kreidberg J, Sorokin L, Georges-Labouesse E. Synergistic activities of alpha3 and alpha6 integrins are required during apical ectodermal ridge formation and organogenesis in the mouse. Development. 1999;126(17):3957–3968. doi: 10.1242/dev.126.17.3957. [DOI] [PubMed] [Google Scholar]
  38. Dudakova L, Liskova P, Trojek T, Palos M, Kalasova S, et al. Changes in lysyl oxidase (LOX) distribution and its decreased activity in keratoconus corneas. Exp Eye Res. 2012;104:74–81. doi: 10.1016/j.exer.2012.09.005. [DOI] [PubMed] [Google Scholar]
  39. Dupps WJ, Jr, Wilson SE. Biomechanics and wound healing in the cornea. Exp Eye Res. 2006;83(4):709–720. doi: 10.1016/j.exer.2006.03.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Ecoiffier T, El Annan J, Rashid S, Schaumberg D, Dana R. Modulation of integrin alpha4beta1 (VLA-4) in dry eye disease. Arch Ophthalmol. 2008;126(12):1695–1699. doi: 10.1001/archopht.126.12.1695. [DOI] [PubMed] [Google Scholar]
  41. Edmund C. Corneal tissue mass in normal and keratoconic eyes. In vivo estimation based on area of horizontal optical sections. Acta Ophthalmol (Copenh) 1988;66(3):305–308. doi: 10.1111/j.1755-3768.1988.tb04601.x. [DOI] [PubMed] [Google Scholar]
  42. Efron N, Hollingsworth JG. New perspectives on keratoconus as revealed by corneal confocal microscopy. Clin Exp Optom. 2008;91(1):34–55. doi: 10.1111/j.1444-0938.2007.00195.x. [DOI] [PubMed] [Google Scholar]
  43. Ehlers N, Sorensen T, Bramsen T, Poulsen EH. Central corneal thickness in newborns and children. Acta Ophthalmol (Copenh) 1976;54(3):285–290. doi: 10.1111/j.1755-3768.1976.tb01257.x. [DOI] [PubMed] [Google Scholar]
  44. Elhalis H, Azizi B, Jurkunas UV. Fuchs endothelial corneal dystrophy. Ocul Surf. 2010;8(4):173–184. doi: 10.1016/s1542-0124(12)70232-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Ellison JA, Velier JJ, Spera P, Jonak ZL, Wang X, et al. Osteopontin and its integrin receptor alpha(v)beta3 are upregulated during formation of the glial scar after focal stroke. Stroke. 1998;29(8):1698–1706. doi: 10.1161/01.str.29.8.1698. [DOI] [PubMed] [Google Scholar]
  46. Faralli JA, Newman JR, Sheibani N, Dedhar S, Peters DM. Integrin-linked kinase regulates integrin signaling in human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 2011;52(3):1684–1692. doi: 10.1167/iovs.10-6397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Fassler R, Meyer M. Consequences of lack of beta 1 integrin gene expression in mice. Genes Dev. 1995;9(15):1896–1908. doi: 10.1101/gad.9.15.1896. [DOI] [PubMed] [Google Scholar]
  48. Fiedler LR, Schonherr E, Waddington R, Niland S, Seidler DG, et al. Decorin regulates endothelial cell motility on collagen I through activation of insulin-like growth factor I receptor and modulation of alpha2beta1 integrin activity. J Biol Chem. 2008;283(25):17406–17415. doi: 10.1074/jbc.M710025200. [DOI] [PubMed] [Google Scholar]
  49. Folger PA, Zekaria D, Grotendorst G, Masur SK. Transforming growth factor-beta-stimulated connective tissue growth factor expression during corneal myofibroblast differentiation. Invest Ophthalmol Vis Sci. 2001;42(11):2534–2541. [PubMed] [Google Scholar]
  50. Fontana L, Chen Y, Prijatelj P, Sakai T, Fassler R, et al. Fibronectin is required for integrin alphavbeta6-mediated activation of latent TGF-beta complexes containing LTBP-1. FASEB J. 2005;19(13):1798–1808. doi: 10.1096/fj.05-4134com. [DOI] [PubMed] [Google Scholar]
  51. Francesconi CM, Hutcheon AE, Chung EH, Dalbone AC, Joyce NC, et al. Expression patterns of retinoblastoma and E2F family proteins during corneal development. Invest Ophthalmol Vis Sci. 2000;41(5):1054–1062. [PubMed] [Google Scholar]
  52. Fullwood NJ, Tuft SJ, Malik NS, Meek KM, Ridgway AE, et al. Synchrotron x-ray diffraction studies of keratoconus corneal stroma. Invest Ophthalmol Vis Sci. 1992;33(5):1734–1741. [PubMed] [Google Scholar]
  53. Funderburgh JL, Funderburgh ML, Mann MM, Corpuz L, Roth MR. Proteoglycan expression during transforming growth factor beta -induced keratocyte-myofibroblast transdifferentiation. J Biol Chem. 2001;276(47):44173–44178. doi: 10.1074/jbc.M107596200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Gabbiani G. The myofibroblast in wound healing and fibrocontractive diseases. J Pathol. 2003;200(4):500–503. doi: 10.1002/path.1427. [DOI] [PubMed] [Google Scholar]
  55. Gaudreault M, Vigneault F, Leclerc S, Guerin SL. Laminin reduces expression of the human alpha6 integrin subunit gene by altering the level of the transcription factors Sp1 and Sp3. Invest Ophthalmol Vis Sci. 2007;48(8):3490–3505. doi: 10.1167/iovs.07-0016. [DOI] [PubMed] [Google Scholar]
  56. Georges PC, Miller WJ, Meaney DF, Sawyer ES, Janmey PA. Matrices with compliance comparable to that of brain tissue select neuronal over glial growth in mixed cortical cultures. Biophys J. 2006;90(8):3012–3018. doi: 10.1529/biophysj.105.073114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Grotendorst GR, Rahmanie H, Duncan MR. Combinatorial signaling pathways determine fibroblast proliferation and myofibroblast differentiation. FASEB J. 2004;18(3):469–479. doi: 10.1096/fj.03-0699com. [DOI] [PubMed] [Google Scholar]
  58. Grushkin-Lerner LS, Trinkaus-Randall V. Localization of integrin and syndecan in vivo in a corneal epithelial abrasion and keratectomy. Curr Eye Res. 1991;10(1):75–85. doi: 10.3109/02713689109007612. [DOI] [PubMed] [Google Scholar]
  59. Guidry C, Bradley KM, King JL. Tractional force generation by human muller cells: growth factor responsiveness and integrin receptor involvement. Invest Ophthalmol Vis Sci. 2003;44(3):1355–1363. doi: 10.1167/iovs.02-0046. [DOI] [PubMed] [Google Scholar]
  60. Guo H, Du G, Wang L, Wang D, Hu L, et al. Integrin alpha v beta 6 contributes to maintaining corneal epithelial barrier function. Cell Biol Int. 2013;37(6):593–599. doi: 10.1002/cbin.10076. [DOI] [PubMed] [Google Scholar]
  61. Hanlon SD, Smith CW, Sauter MN, Burns AR (2014) Integrin-dependent neutrophil migration in the injured mouse cornea. Exp Eye Res [DOI] [PMC free article] [PubMed]
  62. Hassell JR, Birk DE. The molecular basis of corneal transparency. Exp Eye Res. 2010;91(3):326–335. doi: 10.1016/j.exer.2010.06.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Haustein J. On the ultrastructure of the developing and adult mouse corneal stroma. Anat Embryol (Berl) 1983;168(2):291–305. doi: 10.1007/BF00315823. [DOI] [PubMed] [Google Scholar]
  64. Hayashida Y, Akama TO, Beecher N, Lewis P, Young RD, et al. Matrix morphogenesis in cornea is mediated by the modification of keratan sulfate by GlcNAc 6-O-sulfotransferase. Proc Natl Acad Sci U S A. 2006;103(36):13333–13338. doi: 10.1073/pnas.0605441103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Helena MC, Baerveldt F, Kim WJ, Wilson SE. Keratocyte apoptosis after corneal surgery. Invest Ophthalmol Vis Sci. 1998;39(2):276–283. [PubMed] [Google Scholar]
  66. Hinz B, Phan SH, Thannickal VJ, Galli A, Bochaton-Piallat ML, et al. The myofibroblast: one function, multiple origins. Am J Pathol. 2007;170(6):1807–1816. doi: 10.2353/ajpath.2007.070112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Hiscott P, Sorokin L, Nagy ZZ, Schlotzer-Schrehardt U, Naumann GO. Keratocytes produce thrombospondin 1: evidence for cell phenotype-associated synthesis. Exp Cell Res. 1996;226(1):140–146. doi: 10.1006/excr.1996.0212. [DOI] [PubMed] [Google Scholar]
  68. Hopfer U, Fukai N, Hopfer H, Wolf G, Joyce N, et al. Targeted disruption of Col8a1 and Col8a2 genes in mice leads to anterior segment abnormalities in the eye. FASEB J. 2005;19(10):1232–1244. doi: 10.1096/fj.04-3019com. [DOI] [PubMed] [Google Scholar]
  69. Hutcheon AE, Guo XQ, Stepp MA, Simon KJ, Weinreb PH, et al. Effect of wound type on Smad 2 and 4 translocation. Invest Ophthalmol Vis Sci. 2005;46(7):2362–2368. doi: 10.1167/iovs.04-0759. [DOI] [PubMed] [Google Scholar]
  70. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell. 2002;110(6):673–687. doi: 10.1016/s0092-8674(02)00971-6. [DOI] [PubMed] [Google Scholar]
  71. Iliaki E, Poulaki V, Mitsiades N, Mitsiades CS, Miller JW, et al. Role of alpha 4 integrin (CD49d) in the pathogenesis of diabetic retinopathy. Invest Ophthalmol Vis Sci. 2009;50(10):4898–4904. doi: 10.1167/iovs.08-2013. [DOI] [PubMed] [Google Scholar]
  72. Imanishi J, Kamiyama K, Iguchi I, Kita M, Sotozono C, et al. Growth factors: importance in wound healing and maintenance of transparency of the cornea. Prog Retin Eye Res. 2000;19(1):113–129. doi: 10.1016/s1350-9462(99)00007-5. [DOI] [PubMed] [Google Scholar]
  73. Jester JV, Barry PA, Lind GJ, Petroll WM, Garana R, et al. Corneal keratocytes: in situ and in vitro organization of cytoskeletal contractile proteins. Invest Ophthalmol Vis Sci. 1994;35(2):730–743. [PubMed] [Google Scholar]
  74. Jester JV, Petroll WM, Barry PA, Cavanagh HD. Expression of alpha-smooth muscle (alpha-SM) actin during corneal stromal wound healing. Invest Ophthalmol Vis Sci. 1995;36(5):809–819. [PubMed] [Google Scholar]
  75. Jester JV, Moller-Pedersen T, Huang J, Sax CM, Kays WT, et al. The cellular basis of corneal transparency: evidence for ‘corneal crystallins’. J Cell Sci. 1999;112(Pt 5):613–622. doi: 10.1242/jcs.112.5.613. [DOI] [PubMed] [Google Scholar]
  76. Jester JV, Huang J, Petroll WM, Cavanagh HD. TGFbeta induced myofibroblast differentiation of rabbit keratocytes requires synergistic TGFbeta, PDGF and integrin signaling. Exp Eye Res. 2002;75(6):645–657. doi: 10.1006/exer.2002.2066. [DOI] [PubMed] [Google Scholar]
  77. Jester JV, Lee YG, Huang J, Houston J, Adams B, et al. Postnatal corneal transparency, keratocyte cell cycle exit and expression of ALDH1A1. Invest Ophthalmol Vis Sci. 2007;48(9):4061–4069. doi: 10.1167/iovs.07-0431. [DOI] [PubMed] [Google Scholar]
  78. John AS, Rothman VL, Tuszynski GP. Thrombospondin-1 (TSP-1) stimulates expression of integrin alpha6 in human breast carcinoma cells: a downstream modulator of TSP-1-induced cellular adhesion. J Oncol. 2010;2010:645376. doi: 10.1155/2010/645376. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Kadler KE, Hill A, Canty-Laird EG. Collagen fibrillogenesis: fibronectin, integrins, and minor collagens as organizers and nucleators. Curr Opin Cell Biol. 2008;20(5):495–501. doi: 10.1016/j.ceb.2008.06.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Kao WW, Liu CY. Roles of lumican and keratocan on corneal transparency. Glycoconj J. 2002;19(4–5):275–285. doi: 10.1023/A:1025396316169. [DOI] [PubMed] [Google Scholar]
  81. Kapp TG, Rechenmacher F, Sobahi TR, Kessler H. Integrin modulators: a patent review. Expert Opin Ther Pat. 2013;23(10):1273–1295. doi: 10.1517/13543776.2013.818133. [DOI] [PubMed] [Google Scholar]
  82. Klenkler B, Sheardown H. Growth factors in the anterior segment: role in tissue maintenance, wound healing and ocular pathology. Exp Eye Res. 2004;79(5):677–688. doi: 10.1016/j.exer.2004.07.008. [DOI] [PubMed] [Google Scholar]
  83. Klingberg F, Hinz B, White ES. The myofibroblast matrix: implications for tissue repair and fibrosis. J Pathol. 2013;229(2):298–309. doi: 10.1002/path.4104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Klotz O, Park JK, Pleyer U, Hartmann C, Baatz H. Inhibition of corneal neovascularization by alpha(v)-integrin antagonists in the rat. Graefes Arch Clin Exp Ophthalmol. 2000;238(1):88–93. doi: 10.1007/s004170050015. [DOI] [PubMed] [Google Scholar]
  85. Klyce SD, Dohlman CH, Tolpin DW. In vivo determination of corneal swelling pressure. Exp Eye Res. 1971;11(2):220–229. doi: 10.1016/s0014-4835(71)80026-x. [DOI] [PubMed] [Google Scholar]
  86. Koch M, Laub F, Zhou P, Hahn RA, Tanaka S, et al. Collagen XXIV, a vertebrate fibrillar collagen with structural features of invertebrate collagens: selective expression in developing cornea and bone. J Biol Chem. 2003;278(44):43236–43244. doi: 10.1074/jbc.M302112200. [DOI] [PubMed] [Google Scholar]
  87. Krachmer JH, Feder RS, Belin MW. Keratoconus and related noninflammatory corneal thinning disorders. Surv Ophthalmol. 1984;28(4):293–322. doi: 10.1016/0039-6257(84)90094-8. [DOI] [PubMed] [Google Scholar]
  88. Kupper TS, Ferguson TA. A potential pathophysiologic role for alpha 2 beta 1 integrin in human eye diseases involving vitreoretinal traction. FASEB J. 1993;7(14):1401–1406. doi: 10.1096/fasebj.7.14.8224612. [DOI] [PubMed] [Google Scholar]
  89. Kyriakides TR, Bornstein P. Matricellular proteins as modulators of wound healing and the foreign body response. Thromb Haemost. 2003;90(6):986–992. doi: 10.1160/TH03-06-0399. [DOI] [PubMed] [Google Scholar]
  90. Larsen M, Artym VV, Green JA, Yamada KM. The matrix reorganized: extracellular matrix remodeling and integrin signaling. Curr Opin Cell Biol. 2006;18(5):463–471. doi: 10.1016/j.ceb.2006.08.009. [DOI] [PubMed] [Google Scholar]
  91. Latvala T, Paallysaho T, Tervo K, Tervo T. Distribution of alpha 6 and beta 4 integrins following epithelial abrasion in the rabbit cornea. Acta Ophthalmol Scand. 1996;74(1):21–25. doi: 10.1111/j.1600-0420.1996.tb00675.x. [DOI] [PubMed] [Google Scholar]
  92. Lauweryns B, van den Oord JJ, Volpes R, Foets B, Missotten L. Distribution of very late activation integrins in the human cornea. An immunohistochemical study using monoclonal antibodies. Invest Ophthalmol Vis Sci. 1991;32(7):2079–2085. [PubMed] [Google Scholar]
  93. Leask A. Targeting the TGFbeta, endothelin-1 and CCN2 axis to combat fibrosis in scleroderma. Cell Signal. 2008;20(8):1409–1414. doi: 10.1016/j.cellsig.2008.01.006. [DOI] [PubMed] [Google Scholar]
  94. Lee JL, Wang MJ, Sudhir PR, Chen GD, Chi CW, et al. Osteopontin promotes integrin activation through outside-in and inside-out mechanisms: OPN-CD44V interaction enhances survival in gastrointestinal cancer cells. Cancer Res. 2007;67(5):2089–2097. doi: 10.1158/0008-5472.CAN-06-3625. [DOI] [PubMed] [Google Scholar]
  95. Lee S, Bowrin K, Hamad AR, Chakravarti S. Extracellular matrix lumican deposited on the surface of neutrophils promotes migration by binding to beta2 integrin. J Biol Chem. 2009;284(35):23662–23669. doi: 10.1074/jbc.M109.026229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Leu ST, Jacques SA, Wingerd KL, Hikita ST, Tolhurst EC, et al. Integrin alpha4beta1 function is required for cell survival in developing retina. Dev Biol. 2004;276(2):416–430. doi: 10.1016/j.ydbio.2004.09.003. [DOI] [PubMed] [Google Scholar]
  97. Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell. 2009;139(5):891–906. doi: 10.1016/j.cell.2009.10.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Li Z, Calzada MJ, Sipes JM, Cashel JA, Krutzsch HC, et al. Interactions of thrombospondins with alpha4beta1 integrin and CD47 differentially modulate T cell behavior. J Cell Biol. 2002;157(3):509–519. doi: 10.1083/jcb.200109098. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Li S, Van Den Diepstraten C, D’Souza SJ, Chan BM, Pickering JG. Vascular smooth muscle cells orchestrate the assembly of type I collagen via alpha2beta1 integrin, RhoA, and fibronectin polymerization. Am J Pathol. 2003;163(3):1045–1056. doi: 10.1016/s0002-9440(10)63464-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Li J, Chen J, Kirsner R. Pathophysiology of acute wound healing. Clin Dermatol. 2007;25(1):9–18. doi: 10.1016/j.clindermatol.2006.09.007. [DOI] [PubMed] [Google Scholar]
  101. Lin CG, Leu SJ, Chen N, Tebeau CM, Lin SX, et al. CCN3 (NOV) is a novel angiogenic regulator of the CCN protein family. J Biol Chem. 2003;278(26):24200–24208. doi: 10.1074/jbc.M302028200. [DOI] [PubMed] [Google Scholar]
  102. Liu CY, Birk DE, Hassell JR, Kane B, Kao WW. Keratocan-deficient mice display alterations in corneal structure. J Biol Chem. 2003;278(24):21672–21677. doi: 10.1074/jbc.M301169200. [DOI] [PubMed] [Google Scholar]
  103. Liu S, Xu SW, Blumbach K, Eastwood M, Denton CP, et al. Expression of integrin beta1 by fibroblasts is required for tissue repair in vivo. J Cell Sci. 2010;123(Pt 21):3674–3682. doi: 10.1242/jcs.070672. [DOI] [PubMed] [Google Scholar]
  104. Liu XJ, Kong FZ, Wang YH, Zheng JH, Wan WD, et al. Lumican accelerates wound healing by enhancing alpha2beta1 integrin-mediated fibroblast contractility. PLoS One. 2013;8(6):e67124. doi: 10.1371/journal.pone.0067124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  105. Ljubimov AV, Huang ZS, Huang GH, Burgeson RE, Gullberg D, et al. Human corneal epithelial basement membrane and integrin alterations in diabetes and diabetic retinopathy. J Histochem Cytochem. 1998;46(9):1033–1041. doi: 10.1177/002215549804600907. [DOI] [PubMed] [Google Scholar]
  106. Ljubimov AV, Saghizadeh M, Pytela R, Sheppard D, Kenney MC. Increased expression of tenascin-C-binding epithelial integrins in human bullous keratopathy corneas. J Histochem Cytochem. 2001;49(11):1341–1350. doi: 10.1177/002215540104901102. [DOI] [PubMed] [Google Scholar]
  107. Luna J, Tobe T, Mousa SA, Reilly TM, Campochiaro PA. Antagonists of integrin alpha v beta 3 inhibit retinal neovascularization in a murine model. Lab Investig. 1996;75(4):563–573. [PubMed] [Google Scholar]
  108. Lund T, Reed RK. Alpha-trinositol inhibits edema generation and albumin extravasation in thermally injured skin. J Trauma. 1994;36(6):761–765. doi: 10.1097/00005373-199406000-00001. [DOI] [PubMed] [Google Scholar]
  109. Maatta M, Vaisanen T, Vaisanen MR, Pihlajaniemi T, Tervo T. Altered expression of type XIII collagen in keratoconus and scarred human cornea: Increased expression in scarred cornea is associated with myofibroblast transformation. Cornea. 2006;25(4):448–453. doi: 10.1097/01.ico.0000183537.45393.1f. [DOI] [PubMed] [Google Scholar]
  110. Majava M, Bishop PN, Hagg P, Scott PG, Rice A, et al. Novel mutations in the small leucine-rich repeat protein/proteoglycan (SLRP) genes in high myopia. Hum Mutat. 2007;28(4):336–344. doi: 10.1002/humu.20444. [DOI] [PubMed] [Google Scholar]
  111. Margadant C, Sonnenberg A. Integrin-TGF-beta crosstalk in fibrosis, cancer and wound healing. EMBO Rep. 2010;11(2):97–105. doi: 10.1038/embor.2009.276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  112. Masur SK, Dewal HS, Dinh TT, Erenburg I, Petridou S. Myofibroblasts differentiate from fibroblasts when plated at low density. Proc Natl Acad Sci U S A. 1996;93(9):4219–4223. doi: 10.1073/pnas.93.9.4219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  113. Matsuba M, Hutcheon AE, Zieske JD. Localization of thrombospondin-1 and myofibroblasts during corneal wound repair. Exp Eye Res. 2011;93(4):534–540. doi: 10.1016/j.exer.2011.06.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Matsuda A, Yoshiki A, Tagawa Y, Matsuda H, Kusakabe M. Corneal wound healing in tenascin knockout mouse. Invest Ophthalmol Vis Sci. 1999;40(6):1071–1080. [PubMed] [Google Scholar]
  115. McCally RL, Freund DE, Zorn A, Bonney-Ray J, Grebe R, et al. Light-scattering and ultrastructure of healed penetrating corneal wounds. Invest Ophthalmol Vis Sci. 2007;48(1):157–165. doi: 10.1167/iovs.06-0935. [DOI] [PMC free article] [PubMed] [Google Scholar]
  116. McDonnell PJ. Refractive surgery. Br J Ophthalmol. 1999;83(11):1257–1260. doi: 10.1136/bjo.83.11.1257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Meek KM, Leonard DW, Connon CJ, Dennis S, Khan S. Transparency, swelling and scarring in the corneal stroma. Eye (Lond) 2003;17(8):927–936. doi: 10.1038/sj.eye.6700574. [DOI] [PubMed] [Google Scholar]
  118. Meek KM, Tuft SJ, Huang Y, Gill PS, Hayes S, et al. Changes in collagen orientation and distribution in keratoconus corneas. Invest Ophthalmol Vis Sci. 2005;46(6):1948–1956. doi: 10.1167/iovs.04-1253. [DOI] [PubMed] [Google Scholar]
  119. Merle B, Malaval L, Lawler J, Delmas P, Clezardin P. Decorin inhibits cell attachment to thrombospondin-1 by binding to a KKTR-dependent cell adhesive site present within the N-terminal domain of thrombospondin-1. J Cell Biochem. 1997;67(1):75–83. [PubMed] [Google Scholar]
  120. Midura RJ, Hascall VC, MacCallum DK, Meyer RF, Thonar EJ, et al. Proteoglycan biosynthesis by human corneas from patients with types 1 and 2 macular corneal dystrophy. J Biol Chem. 1990;265(26):15947–15955. [PubMed] [Google Scholar]
  121. Mishima H, Hibino T, Hara H, Murakami J, Otori T. SPARC from corneal epithelial cells modulates collagen contraction by keratocytes. Invest Ophthalmol Vis Sci. 1998;39(13):2547–2553. [PubMed] [Google Scholar]
  122. Miyazaki K, Okada Y, Yamanaka O, Kitano A, Ikeda K, et al. Corneal wound healing in an osteopontin-deficient mouse. Invest Ophthalmol Vis Sci. 2008;49(4):1367–1375. doi: 10.1167/iovs.07-1007. [DOI] [PubMed] [Google Scholar]
  123. Mohan RR, Gupta R, Mehan MK, Cowden JW, Sinha S. Decorin transfection suppresses profibrogenic genes and myofibroblast formation in human corneal fibroblasts. Exp Eye Res. 2010;91(2):238–245. doi: 10.1016/j.exer.2010.05.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. Mohan RR, Tandon A, Sharma A, Cowden JW, Tovey JC. Significant inhibition of corneal scarring in vivo with tissue-selective, targeted AAV5 decorin gene therapy. Invest Ophthalmol Vis Sci. 2011;52(7):4833–4841. doi: 10.1167/iovs.11-7357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  125. Montiani-Ferreira F, Petersen-Jones S, Cassotis N, Ramsey DT, Gearhart P, et al. Early postnatal development of central corneal thickness in dogs. Vet Ophthalmol. 2003;6(1):19–22. doi: 10.1046/j.1463-5224.2003.00196.x. [DOI] [PubMed] [Google Scholar]
  126. Moodie KL, Hashizume N, Houston DL, Hoopes PJ, Demidenko E, et al. Postnatal development of corneal curvature and thickness in the cat. Vet Ophthalmol. 2001;4(4):267–272. doi: 10.1046/j.1463-5216.2001.00198.x. [DOI] [PubMed] [Google Scholar]
  127. Moreth K, Iozzo RV, Schaefer L. Small leucine-rich proteoglycans orchestrate receptor crosstalk during inflammation. Cell Cycle. 2012;11(11):2084–2091. doi: 10.4161/cc.20316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  128. Muether PS, Dell S, Kociok N, Zahn G, Stragies R, et al. The role of integrin alpha5beta1 in the regulation of corneal neovascularization. Exp Eye Res. 2007;85(3):356–365. doi: 10.1016/j.exer.2007.06.004. [DOI] [PubMed] [Google Scholar]
  129. Murakami J, Nishida T, Otori T. Coordinated appearance of beta 1 integrins and fibronectin during corneal wound healing. J Lab Clin Med. 1992;120(1):86–93. [PubMed] [Google Scholar]
  130. Nandrot EF, Kim Y, Brodie SE, Huang X, Sheppard D, et al. Loss of synchronized retinal phagocytosis and age-related blindness in mice lacking alphavbeta5 integrin. J Exp Med. 2004;200(12):1539–1545. doi: 10.1084/jem.20041447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  131. Netto MV, Mohan RR, Ambrosio R, Jr, Hutcheon AE, Zieske JD, et al. Wound healing in the cornea: a review of refractive surgery complications and new prospects for therapy. Cornea. 2005;24(5):509–522. doi: 10.1097/01.ico.0000151544.23360.17. [DOI] [PubMed] [Google Scholar]
  132. Pal-Ghosh S, Pajoohesh-Ganji A, Brown M, Stepp MA. A mouse model for the study of recurrent corneal epithelial erosions: alpha9beta1 integrin implicated in progression of the disease. Invest Ophthalmol Vis Sci. 2004;45(6):1775–1788. doi: 10.1167/iovs.03-1194. [DOI] [PubMed] [Google Scholar]
  133. Pal-Ghosh S, Blanco T, Tadvalkar G, Pajoohesh-Ganji A, Parthasarathy A, et al. MMP9 cleavage of the beta4 integrin ectodomain leads to recurrent epithelial erosions in mice. J Cell Sci. 2011;124(Pt 15):2666–2675. doi: 10.1242/jcs.085480. [DOI] [PMC free article] [PubMed] [Google Scholar]
  134. Parapuram SK, Huh K, Liu S, Leask A. Integrin beta1 is necessary for the maintenance of corneal structural integrity. Invest Ophthalmol Vis Sci. 2011;52(11):7799–7806. doi: 10.1167/iovs.10-6945. [DOI] [PubMed] [Google Scholar]
  135. Pedersen JA, Swartz MA. Mechanobiology in the third dimension. Ann Biomed Eng. 2005;33(11):1469–1490. doi: 10.1007/s10439-005-8159-4. [DOI] [PubMed] [Google Scholar]
  136. Pellegata NS, Dieguez-Lucena JL, Joensuu T, Lau S, Montgomery KT, et al. Mutations in KERA, encoding keratocan, cause cornea plana. Nat Genet. 2000;25(1):91–95. doi: 10.1038/75664. [DOI] [PubMed] [Google Scholar]
  137. Petrescu MS, Larry CL, Bowden RA, Williams GW, Gagen D, et al. Neutrophil interactions with keratocytes during corneal epithelial wound healing: a role for CD18 integrins. Invest Ophthalmol Vis Sci. 2007;48(11):5023–5029. doi: 10.1167/iovs.07-0562. [DOI] [PMC free article] [PubMed] [Google Scholar]
  138. Petroll WM, Ma L, Jester JV. Direct correlation of collagen matrix deformation with focal adhesion dynamics in living corneal fibroblasts. J Cell Sci. 2003;116(Pt 8):1481–1491. doi: 10.1242/jcs.00357. [DOI] [PubMed] [Google Scholar]
  139. Piatigorsky J. Review: a case for corneal crystallins. J Ocul Pharmacol Ther. 2000;16(2):173–180. doi: 10.1089/jop.2000.16.173. [DOI] [PubMed] [Google Scholar]
  140. Polack FM. Contributions of electron microscopy to the study of corneal pathology. Surv Ophthalmol. 1976;20(6):375–414. doi: 10.1016/0039-6257(76)90066-7. [DOI] [PubMed] [Google Scholar]
  141. Portellinha W, Kuchenbuk M, Nakano K, Oliveira M. Interface fluid and diffuse corneal edema after laser in situ keratomileusis. J Refract Surg. 2001;17(2 Suppl):S192–S195. doi: 10.3928/1081-597X-20010302-08. [DOI] [PubMed] [Google Scholar]
  142. Quantock AJ, Young RD. Development of the corneal stroma, and the collagen-proteoglycan associations that help define its structure and function. Dev Dyn. 2008;237(10):2607–2621. doi: 10.1002/dvdy.21579. [DOI] [PubMed] [Google Scholar]
  143. Rada JA, Cornuet PK, Hassell JR. Regulation of corneal collagen fibrillogenesis in vitro by corneal proteoglycan (lumican and decorin) core proteins. Exp Eye Res. 1993;56(6):635–648. doi: 10.1006/exer.1993.1081. [DOI] [PubMed] [Google Scholar]
  144. Robbins SG, Brem RB, Wilson DJ, O’Rourke LM, Robertson JE, et al. Immunolocalization of integrins in proliferative retinal membranes. Invest Ophthalmol Vis Sci. 1994;35(9):3475–3485. [PubMed] [Google Scholar]
  145. Rodt SA, Reed RK, Ljungstrom M, Gustafsson TO, Rubin K. The anti-inflammatory agent alpha-trinositol exerts its edema-preventing effects through modulation of beta 1 integrin function. Circ Res. 1994;75(5):942–948. doi: 10.1161/01.res.75.5.942. [DOI] [PubMed] [Google Scholar]
  146. Saika S, Okada Y, Miyamoto T, Yamanaka O, Ohnishi Y, et al. Protein expression pattern of collagen type XV in mouse cornea. Graefes Arch Clin Exp Ophthalmol. 2004;242(5):432–436. doi: 10.1007/s00417-003-0854-y. [DOI] [PubMed] [Google Scholar]
  147. Saika S, Yamanaka O, Sumioka T, Miyamoto T, Miyazaki K, et al. Fibrotic disorders in the eye: targets of gene therapy. Prog Retin Eye Res. 2008;27(2):177–196. doi: 10.1016/j.preteyeres.2007.12.002. [DOI] [PubMed] [Google Scholar]
  148. Samuelsson AR, Belvindrah R, Wu C, Muller U, Halfter W. Beta1-integrin signaling is essential for lens fiber survival. Gene Regul Syst Bio. 2007;1:177–189. [PMC free article] [PubMed] [Google Scholar]
  149. Scharffetter-Kochanek K, Lu H, Norman K, van Nood N, Munoz F, et al. Spontaneous skin ulceration and defective T cell function in CD18 null mice. J Exp Med. 1998;188(1):119–131. doi: 10.1084/jem.188.1.119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  150. Segev F, Heon E, Cole WG, Wenstrup RJ, Young F, et al. Structural abnormalities of the cornea and lid resulting from collagen V mutations. Invest Ophthalmol Vis Sci. 2006;47(2):565–573. doi: 10.1167/iovs.05-0771. [DOI] [PubMed] [Google Scholar]
  151. Short SM, Derrien A, Narsimhan RP, Lawler J, Ingber DE, et al. Inhibition of endothelial cell migration by thrombospondin-1 type-1 repeats is mediated by beta1 integrins. J Cell Biol. 2005;168(4):643–653. doi: 10.1083/jcb.200407060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  152. Simirskii VN, Wang Y, Duncan MK. Conditional deletion of beta1-integrin from the developing lens leads to loss of the lens epithelial phenotype. Dev Biol. 2007;306(2):658–668. doi: 10.1016/j.ydbio.2007.04.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  153. Singh V, Santhiago MR, Barbosa FL, Agrawal V, Singh N, et al. Effect of TGFbeta and PDGF-B blockade on corneal myofibroblast development in mice. Exp Eye Res. 2011;93(6):810–817. doi: 10.1016/j.exer.2011.09.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  154. Smolek MK, McCarey BE. Interlamellar adhesive strength in human eyebank corneas. Invest Ophthalmol Vis Sci. 1990;31(6):1087–1095. [PubMed] [Google Scholar]
  155. Song J, Lee YG, Houston J, Petroll WM, Chakravarti S, et al. Neonatal corneal stromal development in the normal and lumican-deficient mouse. Invest Ophthalmol Vis Sci. 2003;44(2):548–557. doi: 10.1167/iovs.02-0592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  156. Spirin KS, Ljubimov AV, Castellon R, Wiedoeft O, Marano M, et al. Analysis of gene expression in human bullous keratopathy corneas containing limiting amounts of RNA. Invest Ophthalmol Vis Sci. 1999;40(13):3108–3115. [PubMed] [Google Scholar]
  157. Stephens LE, Sutherland AE, Klimanskaya IV, Andrieux A, Meneses J, et al. Deletion of beta 1 integrins in mice results in inner cell mass failure and peri-implantation lethality. Genes Dev. 1995;9(15):1883–1895. doi: 10.1101/gad.9.15.1883. [DOI] [PubMed] [Google Scholar]
  158. Stepp MA. Corneal integrins and their functions. Exp Eye Res. 2006;83(1):3–15. doi: 10.1016/j.exer.2006.01.010. [DOI] [PubMed] [Google Scholar]
  159. Stepp MA, Spurr-Michaud S, Gipson IK. Integrins in the wounded and unwounded stratified squamous epithelium of the cornea. Invest Ophthalmol Vis Sci. 1993;34(5):1829–1844. [PubMed] [Google Scholar]
  160. Stepp MA, Zhu L, Cranfill R. Changes in beta 4 integrin expression and localization in vivo in response to corneal epithelial injury. Invest Ophthalmol Vis Sci. 1996;37(8):1593–1601. [PubMed] [Google Scholar]
  161. Stepp MA, Gibson HE, Gala PH, Iglesia DD, Pajoohesh-Ganji A, et al. Defects in keratinocyte activation during wound healing in the syndecan-1-deficient mouse. J Cell Sci. 2002;115(Pt 23):4517–4531. doi: 10.1242/jcs.00128. [DOI] [PubMed] [Google Scholar]
  162. Stramer BM, Zieske JD, Jung JC, Austin JS, Fini ME. Molecular mechanisms controlling the fibrotic repair phenotype in cornea: implications for surgical outcomes. Invest Ophthalmol Vis Sci. 2003;44(10):4237–4246. doi: 10.1167/iovs.02-1188. [DOI] [PubMed] [Google Scholar]
  163. Sumioka T, Kitano A, Flanders KC, Okada Y, Yamanaka O, et al. Impaired cornea wound healing in a tenascin C-deficient mouse model. Lab Investig. 2013;93(2):207–217. doi: 10.1038/labinvest.2012.157. [DOI] [PubMed] [Google Scholar]
  164. Sun M, Chen S, Adams SM, Florer JB, Liu H, et al. Collagen V is a dominant regulator of collagen fibrillogenesis: dysfunctional regulation of structure and function in a corneal-stroma-specific Col5a1-null mouse model. J Cell Sci. 2011;124(Pt 23):4096–4105. doi: 10.1242/jcs.091363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  165. Sundarraj N, Fite D, Belak R, Sundarraj S, Rada J, et al. Proteoglycan distribution during healing of corneal stromal wounds in chick. Exp Eye Res. 1998;67(4):433–442. doi: 10.1006/exer.1998.0540. [DOI] [PubMed] [Google Scholar]
  166. Takada Y, Ye X, Simon S. The integrins. Genome Biol. 2007;8(5):215. doi: 10.1186/gb-2007-8-5-215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  167. Thalasselis A, Taie HF, Etchepareborda J, Selim A. Keratoconus, magnesium deficiency, type A behavior, and allergy. Am J Optom Physiol Optic. 1988;65(6):499–505. doi: 10.1097/00006324-198806000-00010. [DOI] [PubMed] [Google Scholar]
  168. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol. 2002;3(5):349–363. doi: 10.1038/nrm809. [DOI] [PubMed] [Google Scholar]
  169. Tuori AJ, Virtanen I, Aine E, Kalluri R, Miner JH, et al. The immunohistochemical composition of corneal basement membrane in keratoconus. Curr Eye Res. 1997;16(8):792–801. doi: 10.1076/ceyr.16.8.792.8989. [DOI] [PubMed] [Google Scholar]
  170. Vigneault F, Zaniolo K, Gaudreault M, Gingras ME, Guerin SL. Control of integrin genes expression in the eye. Prog Retin Eye Res. 2007;26(2):99–161. doi: 10.1016/j.preteyeres.2006.10.004. [DOI] [PubMed] [Google Scholar]
  171. Vorkauf W, Vorkauf M, Nolle B, Duncker G. Adhesion molecules in normal and pathological corneas. An immunohistochemical study using monoclonal antibodies. Graefes Arch Clin Exp Ophthalmol. 1995;233(4):209–219. doi: 10.1007/BF00183594. [DOI] [PubMed] [Google Scholar]
  172. Wang IJ, Chiang TH, Shih YF, Hsiao CK, Lu SC, et al. The association of single nucleotide polymorphisms in the 5′-regulatory region of the lumican gene with susceptibility to high myopia in Taiwan. Mol Vis. 2006;12:852–857. [PubMed] [Google Scholar]
  173. Wenstrup RJ, Florer JB, Brunskill EW, Bell SM, Chervoneva I, et al. Type V collagen controls the initiation of collagen fibril assembly. J Biol Chem. 2004;279(51):53331–53337. doi: 10.1074/jbc.M409622200. [DOI] [PubMed] [Google Scholar]
  174. Wenstrup RJ, Florer JB, Davidson JM, Phillips CL, Pfeiffer BJ, et al. Murine model of the Ehlers-Danlos syndrome. col5a1 haploinsufficiency disrupts collagen fibril assembly at multiple stages. J Biol Chem. 2006;281(18):12888–12895. doi: 10.1074/jbc.M511528200. [DOI] [PubMed] [Google Scholar]
  175. Whitcher JP, Srinivasan M, Upadhyay MP. Corneal blindness: a global perspective. Bull World Health Organ. 2001;79(3):214–221. [PMC free article] [PubMed] [Google Scholar]
  176. Wilson SE. Analysis of the keratocyte apoptosis, keratocyte proliferation, and myofibroblast transformation responses after photorefractive keratectomy and laser in situ keratomileusis. Trans Am Ophthalmol Soc. 2002;100:411–433. [PMC free article] [PubMed] [Google Scholar]
  177. Wilson SE. Corneal myofibroblast biology and pathobiology: generation, persistence, and transparency. Exp Eye Res. 2012;99:78–88. doi: 10.1016/j.exer.2012.03.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  178. Wilson SE, Chaurasia SS, Medeiros FW (2007) Apoptosis in the initiation, modulation and termination of the corneal wound healing response. Exp Eye Res 85(3):305–311 [DOI] [PMC free article] [PubMed]
  179. Wilson SE, Liu JJ, Mohan RR. Stromal-epithelial interactions in the cornea. Prog Retin Eye Res. 1999;18(3):293–309. doi: 10.1016/s1350-9462(98)00017-2. [DOI] [PubMed] [Google Scholar]
  180. Winnemoller M, Schmidt G, Kresse H. Influence of decorin on fibroblast adhesion to fibronectin. Eur J Cell Biol. 1991;54(1):10–17. [PubMed] [Google Scholar]
  181. Wipff PJ, Hinz B. Integrins and the activation of latent transforming growth factor beta1—an intimate relationship. Eur J Cell Biol. 2008;87(8–9):601–615. doi: 10.1016/j.ejcb.2008.01.012. [DOI] [PubMed] [Google Scholar]
  182. Wipff PJ, Rifkin DB, Meister JJ, Hinz B. Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix. J Cell Biol. 2007;179(6):1311–1323. doi: 10.1083/jcb.200704042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  183. Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003;135(5):620–627. doi: 10.1016/s0002-9394(02)02220-1. [DOI] [PubMed] [Google Scholar]
  184. Wong VW, Rustad KC, Akaishi S, Sorkin M, Glotzbach JP, et al. Focal adhesion kinase links mechanical force to skin fibrosis via inflammatory signaling. Nat Med. 2011;18(1):148–152. doi: 10.1038/nm.2574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  185. Yang JT, Rayburn H, Hynes RO. Embryonic mesodermal defects in alpha 5 integrin-deficient mice. Development. 1993;119(4):1093–1105. doi: 10.1242/dev.119.4.1093. [DOI] [PubMed] [Google Scholar]
  186. Young BB, Zhang G, Koch M, Birk DE. The roles of types XII and XIV collagen in fibrillogenesis and matrix assembly in the developing cornea. J Cell Biochem. 2002;87(2):208–220. doi: 10.1002/jcb.10290. [DOI] [PubMed] [Google Scholar]
  187. Zeltz C, Brezillon S, Kapyla J, Eble JA, Bobichon H, et al. Lumican inhibits cell migration through alpha2beta1 integrin. Exp Cell Res. 2010;316(17):2922–2931. doi: 10.1016/j.yexcr.2010.08.002. [DOI] [PubMed] [Google Scholar]
  188. Zhang G, Chen S, Goldoni S, Calder BW, Simpson HC, et al. Genetic evidence for the coordinated regulation of collagen fibrillogenesis in the cornea by decorin and biglycan. J Biol Chem. 2009;284(13):8888–8897. doi: 10.1074/jbc.M806590200. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Cell Communication and Signaling are provided here courtesy of The International CCN Society

RESOURCES